| Dr Tessa L Smit, MD | |
|
48 Sanderson St, Greenfield, MA 01301-2778 | |
| (413) 773-2626 | |
| (413) 773-2629 |
| Full Name | Dr Tessa L Smit |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 12 Years |
| Location | 48 Sanderson St, Greenfield, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205181484 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 274201 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baystate Franklin Medical Center | Greenfield, MA | Hospital |
| Cooley Dickinson Hospital Inc,the | Northampton, MA | Hospital |
| Baystate Medical Center | Springfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baystate Medical Practices Inc | 5991602971 | 1015 |
News Archive
Akeso Medical Imaging BV, announces today the start of a clinical study with their novel imaging device for assessment of joint inflammation in patient with rheumatoid arthritis (RA). In this proof of concept study, Akeso's imaging device will be compared to other methods to assess disease status, such as the DAS-28 score, Ultrasound and in some cases MRI. The study will be performed at the University Medical Center Utrecht (UMC Utrecht) in cooperation with Regional Rheumatology Centre Eindhoven (RRC). Seventy subjects will be included; sixty RA patients with varying degrees of inflammation of the joints of hands and wrists at the time of examination and a control group of ten subjects.
AB SCIEX, a global leader in analytical technologies, today announced the launch of the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe.
When adolescent females visit a pediatric emergency department with complaints that may signal a sexually transmitted infection, white youths are less likely to be tested than blacks, according to a study to be presented Saturday, April 30, at the Pediatric Academic Societies annual meeting in Denver.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
› Verified 6 days ago
| Entity Name | Baystate Medical Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548205909 PECOS PAC ID: 5991602971 Enrollment ID: O20040225000080 |
News Archive
Akeso Medical Imaging BV, announces today the start of a clinical study with their novel imaging device for assessment of joint inflammation in patient with rheumatoid arthritis (RA). In this proof of concept study, Akeso's imaging device will be compared to other methods to assess disease status, such as the DAS-28 score, Ultrasound and in some cases MRI. The study will be performed at the University Medical Center Utrecht (UMC Utrecht) in cooperation with Regional Rheumatology Centre Eindhoven (RRC). Seventy subjects will be included; sixty RA patients with varying degrees of inflammation of the joints of hands and wrists at the time of examination and a control group of ten subjects.
AB SCIEX, a global leader in analytical technologies, today announced the launch of the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe.
When adolescent females visit a pediatric emergency department with complaints that may signal a sexually transmitted infection, white youths are less likely to be tested than blacks, according to a study to be presented Saturday, April 30, at the Pediatric Academic Societies annual meeting in Denver.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tessa L Smit, MD 280 Chestnut Street 2nd Floor, Springfield, MA 01199-1001 Ph: (413) 794-5700 | Dr Tessa L Smit, MD 48 Sanderson St, Greenfield, MA 01301-2778 Ph: (413) 773-2626 |
News Archive
Akeso Medical Imaging BV, announces today the start of a clinical study with their novel imaging device for assessment of joint inflammation in patient with rheumatoid arthritis (RA). In this proof of concept study, Akeso's imaging device will be compared to other methods to assess disease status, such as the DAS-28 score, Ultrasound and in some cases MRI. The study will be performed at the University Medical Center Utrecht (UMC Utrecht) in cooperation with Regional Rheumatology Centre Eindhoven (RRC). Seventy subjects will be included; sixty RA patients with varying degrees of inflammation of the joints of hands and wrists at the time of examination and a control group of ten subjects.
AB SCIEX, a global leader in analytical technologies, today announced the launch of the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe.
When adolescent females visit a pediatric emergency department with complaints that may signal a sexually transmitted infection, white youths are less likely to be tested than blacks, according to a study to be presented Saturday, April 30, at the Pediatric Academic Societies annual meeting in Denver.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
› Verified 6 days ago
Dr. Savitri Rambissoon, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 48 Sanderson St, Greenfield, MA 01301 Phone: 413-773-2626 Fax: 413-773-2629 | |
Dr. Satish B Muthavarapu, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 48 Sanderson Street, Suite 2, Greenfield, MA 01301 Phone: 413-773-2626 Fax: 413-773-2629 | |
Dr. Alan D Mcclelland, MD Surgery Medicare: Medicare Enrolled Practice Location: 48 Sanderson St, 2nd Floor, Greenfield, MA 01301 Phone: 413-773-2626 Fax: 413-773-2629 | |
Thampi K Ampadi, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 48 Sanderson St, 2nd Fl, Greenfield, MA 01301 Phone: 413-773-2626 Fax: 413-773-2629 | |
Kaitlin P Debbink, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 48 Sanderson Street, Greenfield, MA 01301 Phone: 413-773-2626 Fax: 413-773-2629 | |
Douglas P Fusonie, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 92 Ferrante Ave, Greenfield, MA 01301 Phone: 413-774-2074 |